PSA Testing for Prostate Cancer in Patients What You Need to Know
- paulcleaveland
- Aug 4
- 8 min read
A PSA blood test can feel simple: one needle, one number, and a result that looks clear. The reality is more nuanced. PSA testing can help find prostate cancer early, but it can also lead to worry, extra scans, biopsies, and treatment for cancers that may never have caused harm.
That does not mean the test is “good” or “bad”. It means the decision deserves a clear conversation.
This guide explains what PSA is, when testing may be useful, what can affect the result, and what usually happens next. It is written for general information only and does not replace advice from a GP, urologist, or specialist nurse.
What PSA is and why it matters
PSA stands for prostate-specific antigen. It is a protein made by the prostate gland. Most PSA stays in semen, but a small amount enters the blood. A PSA test measures that amount.
A raised PSA level can be linked to prostate cancer, but it does not prove cancer is present. PSA can also rise for several non-cancer reasons, including:
An enlarged prostate, also called benign prostatic enlargement
Prostatitis, which is inflammation or infection of the prostate
A recent urinary tract infection
Recent ejaculation
Recent vigorous cycling
Recent prostate examination or catheter use
Age, because PSA often rises as the prostate gets larger over time
Some people with prostate cancer have only a mildly raised PSA. A smaller number can have prostate cancer even when the PSA result is within the expected range. This is why PSA testing works best as part of a wider assessment, not as a stand-alone answer.
Who may consider a PSA test
In the UK, there is no routine national PSA screening programme for all men. This is because the benefits and harms are finely balanced. Instead, people can discuss the test with a GP and decide based on age, symptoms, risk factors, and personal preferences.
A PSA test may be considered if:
There are urinary symptoms that need checking
There is a higher risk of prostate cancer
There is a family history of prostate cancer
A person wants to understand the pros and cons of testing
A clinician recommends it as part of follow-up or monitoring
Most guidance focuses on men over 50 having an informed choice about testing. People at higher risk may discuss testing earlier.
Higher risk groups include:
Men with a father or brother who has had prostate cancer
Men with several close relatives affected by prostate, breast, or ovarian cancer
Black men, who have a higher lifetime risk of prostate cancer
People known to carry certain inherited gene changes, such as BRCA2
Some trans women, non-binary people assigned male at birth, and intersex people may also have a prostate. PSA testing may still be relevant, depending on anatomy, age, hormone treatment, and medical history.
Symptoms that should not be ignored
Prostate cancer often causes no symptoms in its early stages. When urinary symptoms appear, they are more often due to benign prostate enlargement than cancer. Even so, symptoms should be assessed.
Speak to a GP if there is:
Difficulty starting to pass urine
A weak or interrupted urine flow
Needing to pass urine often, especially at night
A sudden urge to pass urine
Blood in urine or semen
Pain when passing urine
New pain in the back, hips, or pelvis
Unexplained weight loss or tiredness
Blood in the urine, severe pain, fever, or inability to pass urine needs urgent medical advice.
PSA testing may be part of the assessment, but it is rarely the only step. A clinician may also ask about symptoms, medicines, family history, and recent infections. They may examine the abdomen and, if appropriate, offer a digital rectal examination to feel the prostate.
What happens before the test
A PSA test is a routine blood test. The preparation matters because temporary factors can push PSA up and make the result harder to interpret.
Before testing, a GP or nurse may ask about:
Recent urinary infection
Current urinary symptoms
Recent ejaculation
Recent heavy exercise or cycling
Prostate procedures or catheter use
Medicines that can affect PSA
Previous PSA results
If there is a urinary tract infection, the test may be delayed until after treatment and recovery. If a recent activity could affect the result, the clinician may advise waiting. This helps avoid unnecessary alarm.
The blood sample is usually taken from a vein in the arm. The result is then interpreted in context. There is no single “normal” PSA number that fits everyone. Age, prostate size, symptoms, and previous PSA levels all matter.
What a PSA result can and cannot tell you
A PSA result is often reported as a number in nanograms per millilitre of blood. A GP may describe it as within the expected range, borderline, or raised for age.
A lower PSA is generally reassuring, but it does not remove all risk.
A raised PSA means further assessment may be needed, but it does not mean cancer has been found.
A rising PSA over time may be more concerning than one isolated result, especially if the rise is steady and unexplained.
The test can lead to three broad outcomes.
Result pattern | What it may mean | What may happen next |
PSA is within the expected range | Cancer is less likely, but not impossible | Review symptoms and risk, repeat testing only if needed |
PSA is borderline or mildly raised | Benign enlargement, inflammation, infection, or cancer are possible | Repeat PSA, urine test, examination, or referral depending on risk |
PSA is clearly raised or rising | Further checks are more likely to be needed | Referral for specialist assessment, often including MRI |
The key point is that PSA is a risk signal, not a diagnosis.
The benefits of PSA testing
The main potential benefit is early detection. Some prostate cancers are aggressive. Finding them before they spread can open the door to treatment when it is most likely to help.
PSA testing may also:
Provide a baseline for future comparison
Help investigate urinary symptoms
Support monitoring after prostate cancer treatment
Help track known prostate conditions under medical care
Give some people reassurance after an informed discussion
For someone with higher risk, the balance may lean more strongly towards testing. Family history, ethnicity, age, and general health all affect the decision.
The test can be especially useful when combined with modern pathways. In many UK settings, MRI is used before biopsy when further assessment is needed. This can help target areas of concern and may reduce unnecessary biopsies.
The possible downsides of PSA testing
The downsides are real, and they are the reason PSA testing is not offered as a blanket screening test to everyone.
False positives can cause worry
A false positive means PSA is raised but cancer is not present. This can lead to anxiety, repeat testing, scans, and sometimes biopsy.
A biopsy can cause discomfort, bleeding, infection, and short-term urinary or sexual side effects. Serious complications are uncommon, but they can happen.
False negatives can give false reassurance
A false negative means the PSA level looks reassuring even though cancer is present. This is less common, but it matters. Symptoms or strong risk factors should not be ignored just because one PSA result is low.
Overdiagnosis can lead to difficult choices
Some prostate cancers grow so slowly that they would never cause symptoms during a person’s lifetime. PSA testing can find these cancers. That can lead to treatment decisions that may not have been needed.
Treatment for prostate cancer can be life-saving, but it can also cause side effects such as urinary leakage, erection problems, bowel symptoms, and changes in fertility. For low-risk prostate cancer, doctors may recommend active surveillance rather than immediate treatment. This means careful monitoring with tests and scans, with treatment only if the cancer shows signs of progression.
What happens if PSA is raised
A raised PSA result usually leads to a step-by-step process rather than an immediate diagnosis.
The GP may repeat the test, especially if there is a possible temporary cause. They may also check urine, review symptoms, and examine the prostate. If concern remains, they may refer to a urology team.
Specialist assessment may include:
Review of PSA level and previous results
Physical examination
MRI scan of the prostate
Biopsy if imaging or risk level suggests it is needed
An MRI scan can show whether there are areas that look suspicious. If a biopsy is recommended, small samples of prostate tissue are taken and examined under a microscope. This is the test that can confirm whether cancer is present.
If cancer is found, the team will look at:
The grade of the cancer
The stage, meaning whether it appears contained or has spread
PSA level and trend
MRI and biopsy findings
Age, general health, and personal priorities
Treatment options may include active surveillance, surgery, radiotherapy, hormone therapy, or combinations of treatments. The right choice depends on the cancer and the person.
How to prepare for a useful PSA conversation
A good PSA discussion is not just “Do you want the test?” It should cover personal risk, possible results, and what each result could lead to.
Before the appointment, it can help to write down:
Urinary symptoms and when they started
Any blood in urine or semen
Family history of prostate, breast, or ovarian cancer
Ethnic background, if relevant to risk assessment
Current medicines and supplements
Recent infections or procedures
What matters most, such as avoiding missed cancer or avoiding unnecessary tests
Useful questions to ask include:
Is PSA testing suitable for me at my age and risk level?
Could anything make my PSA result unreliable right now?
What PSA level would lead to repeat testing or referral?
If my PSA is raised, what would happen next?
If my PSA is normal, should I test again in future?
Would my general health affect whether testing is useful?
These questions help turn PSA testing from a one-off blood test into an informed decision.
When monitoring matters after treatment or diagnosis
PSA testing is also used after prostate cancer diagnosis or treatment. In that setting, the meaning is different.
After surgery to remove the prostate, PSA is expected to fall to a very low level. A later rise may suggest that prostate cells remain or have returned. After radiotherapy, PSA usually falls more gradually, and doctors look at the trend over time.
For people on active surveillance, PSA is one part of monitoring. It may be combined with MRI, repeat biopsy, and clinical review. A change in PSA does not always mean the cancer has changed, but it can prompt a closer look.
This is why patients already under urology care should follow the testing schedule set by their specialist team.
Making a balanced decision
PSA Testing for Prostate Cancer in Patients is not a simple yes or no issue. The test can help detect important cancers early, but it can also find slow-growing cancers and trigger further procedures.
A balanced decision usually comes down to three questions.
What is the personal risk?
Age, family history, ethnicity, symptoms, and medical history all matter.
What would happen after the result?
A raised PSA may lead to repeat blood tests, MRI, biopsy, or monitoring.
What matters most to the person being tested?
Some people value early detection above all else. Others are more concerned about overdiagnosis and unnecessary treatment. Both views are reasonable when based on clear information.
The best next step is a calm conversation with a GP or specialist nurse. Ask what the result could mean, what might affect it, and what the plan would be for both a normal and a raised result. A PSA test becomes far more useful when it is paired with context, follow-up, and shared decision-making.
To find out more book an appointment to see Mr Cleaveland.
Comments